US/UK/Canada

Share

Quotes

“Throughout my career, I’ve been driven by and focused on bringing innovative medical device therapies to the market, and I believe that SmartFuse represents the future of medical devices; smart connected implants that provide therapeutic benefits and real-time data to support clinical decision making. Ultimately, I believe these implants will have significant advantages to traditional implants in addressing unmet clinical needs and improving patient outcomes.”
Benjamin A. Hertzog, PhD
I believe that SmartFuse represents the future of medical devices, where we have smart implants designed to not only provide a therapeutic benefit, but to also provide data to support real-time clinical decision making throughout the duration of therapy. The industry has been talking about this paradigm for quite a while now, but with SmartFuse, the future is here.
Benjamin Hertzog
Pick a time period -
Tags ( Active)

Intelligent Implants Taps Leading Medical Device Entrepreneur, Benjamin A. Hertzog, PhD, as CEO

Highly accomplished, industry expert brings over 20 years of experienceHouston, Texas/Gothenburg, Sweden/Cork, Ireland – Intelligent Implants Ltd., a development-stage digital medicine and orthopedics start-up, has named Benjamin A. Hertzog, Ph.D., as Chief Executive Officer effective immediately. The company tapped Dr. Hertzog to build upon the foundation of the innovative technology established over recent years. On the heels of receiving FDA Breakthrough Device Designation and an award of €4.5 million in blended funding from the European Union EIC Accelerator for its SmartFuse®

Intelligent Implants scores €4.5 million blended financing from EIC Accelerator

EIC funding will accelerate the completion of the clinical pilot trial and the preparation of the pivotal study of the SmartFuse® systemSwedish-Irish smart orthopaedics start-up, Intelligent Implants has been awarded €4.5 million blended funding from the European Union (EU) EIC Accelerator programme. Spinal fusion surgery, one of the most expensive and invasive medical procedures, is the only option for a large population of patients suffering from chronic back pain. Unfortunately, after many decades of progress, roughly 18% of 1.5M worldwide annual spinal fusion surgeries still fail,

FDA grants Breakthrough Device Designation for Smart orthopedic implants

Cork, Ireland, Gothenburg, Sweden & Houston, Texas (May 28, 2021) -- Intelligent Implants Ltd (II), a development-stage, medical device company with offices in Cork, Ireland, Gothenburg, Sweden and Houston, Texas has announced today that its SmartFuse® system has received Breakthrough Device Designation by the US Food and Drug Administration (FDA). Intelligent Implants SmartFuse technology is a wirelessly enabled orthopedics platform that has been designed to remotely stimulate, control, and monitor bone growth. The goal of the SmartFuse system is to accelerate bone growth and provide

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Media